The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal
Research Stability & Handling Profile This blend exhibits notable stability characteristics that distinguish it within the peptide research space
Tirzepatide holds FDA approvals as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well
When insulin is low, blood sugar rises, Hcy levels increase, cysteine drops, and ATP production slows, causing more ROS and cell damage
Clinical trials have shown that it not only lowers blood sugar levels but also promotes significant weight loss, far exceeding the results of previous medications